Subsequently, expression levels of CHROMR in peripheral blood mononuclear cells of multiple sclerosis patients (n = 38) were tested by quantitative PCR and revealed a significant downregulation of CHROMR compared to a control group of healthy volunteers (n = 17). This evidence concerns the gene CHROMR and multiple sclerosis.